| Heart disease and stroke statistics—2017 update: a report from the American Heart Association EJ Benjamin, MJ Blaha, SE Chiuve, M Cushman, SR Das, R Deo, ... circulation 135 (10), e146-e603, 2017 | 17124 | 2017 |
| Heart disease and stroke statistics—2014 update: a report from the American Heart Association AS Go, D Mozaffarian, VL Roger, EJ Benjamin, JD Berry, MJ Blaha, S Dai, ... circulation 129 (3), e28-e292, 2014 | 16645 | 2014 |
| A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease PW Serruys, P De Jaegere, F Kiemeneij, C Macaya, W Rutsch, ... New England Journal of Medicine 331 (8), 489-495, 1994 | 6290 | 1994 |
| Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease PW Serruys, MC Morice, AP Kappetein, A Colombo, DR Holmes, MJ Mack, ... New England journal of medicine 360 (10), 961-972, 2009 | 5287 | 2009 |
| From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part I M Naghavi, P Libby, E Falk, SW Casscells, S Litovsky, J Rumberger, ... Circulation 108 (14), 1664-1672, 2003 | 4952 | 2003 |
| Comparison of coronary-artery bypass surgery and stenting for the treatment of multivessel disease PW Serruys, F Unger, JE Sousa, A Jatene, HJRM Bonnier, ... New England Journal of Medicine 344 (15), 1117-1124, 2001 | 1694 | 2001 |
| Lack of neointimal proliferation after implantation of sirolimus-coated stents in human coronary arteries: a quantitative coronary angiography and three-dimensional … JE Sousa, MA Costa, A Abizaid, AS Abizaid, F Feres, IMF Pinto, ... Circulation 103 (2), 192-195, 2001 | 1294 | 2001 |
| Fluvastatin for prevention of cardiac events following successful first percutaneous coronary intervention: a randomized controlled trial PWJC Serruys, P de Feyter, C Macaya, N Kokott, J Puel, M Vrolix, ... Jama 287 (24), 3215-3222, 2002 | 1066 | 2002 |
| Coronary-artery stents PW Serruys, MJB Kutryk, ATL Ong New England Journal of Medicine 354 (5), 483-495, 2006 | 1036 | 2006 |
| Expert review document on methodology, terminology, and clinical applications of optical coherence tomography: physical principles, methodology of image acquisition, and … F Prati, E Regar, GS Mintz, E Arbustini, C Di Mario, IK Jang, T Akasaka, ... European heart journal 31 (4), 401-415, 2010 | 921 | 2010 |
| Five-year outcomes after coronary stenting versus bypass surgery for the treatment of multivessel disease: the final analysis of the Arterial Revascularization Therapies Study … PW Serruys, ATL Ong, LA van Herwerden, JE Sousa, A Jatene, ... Journal of the American College of Cardiology 46 (4), 575-581, 2005 | 847 | 2005 |
| Unrestricted Utilization of Sirolimus-Eluting Stents Compared With Conventional Bare Stent Implantation in the “Real World” The R apamycin-E luting S tent E valuated A t R … PA Lemos, PW Serruys, RT van Domburg, F Saia, CA Arampatzis, A Hoye, ... Circulation 109 (2), 190-195, 2004 | 838 | 2004 |
| Thrombolysis with tissue plasminogen activator in acute myocardial infarction: no additional benefit from immediate percutaneous coronary angioplasty ML Simoons, A Betriu, J Col, R Von Essen, J Lubsen, PL Michel, ... The Lancet 331 (8579), 197-203, 1988 | 787 | 1988 |
| Biolimus-eluting stent with biodegradable polymer versus sirolimus-eluting stent with durable polymer for coronary revascularisation (LEADERS): a randomised non-inferiority trial S Windecker, PW Serruys, S Wandel, P Buszman, S Trznadel, A Linke, ... The Lancet 372 (9644), 1163-1173, 2008 | 779 | 2008 |
| New frontiers in cardiology: drug-eluting stents: Part I JE Sousa, PW Serruys, MA Costa Circulation 107 (17), 2274-2279, 2003 | 642 | 2003 |
| Sirolimus-vs paclitaxel-eluting stents in de novo coronary artery lesions: the REALITY trial: a randomized controlled trial MC Morice, A Colombo, B Meier, P Serruys, C Tamburino, G Guagliumi, ... Jama 295 (8), 895-904, 2006 | 635 | 2006 |
| Everolimus-eluting stent versus bare-metal stent in ST-segment elevation myocardial infarction (EXAMINATION): 1 year results of a randomised controlled trial M Sabate, A Cequier, A Iñiguez, A Serra, R Hernandez-Antolin, V Mainar, ... The Lancet 380 (9852), 1482-1490, 2012 | 538 | 2012 |
| TAXUS III Trial: in-stent restenosis treated with stent-based delivery of paclitaxel incorporated in a slow-release polymer formulation K Tanabe, PW Serruys, E Grube, PC Smits, G Selbach, ... Circulation 107 (4), 559-564, 2003 | 525 | 2003 |
| A comparison of hirudin with heparin in the prevention of restenosis after coronary angioplasty PW Serruys, JPR Herrman, R Simon, W Rutsch, C Bode, GJ Laarman, ... New England Journal of Medicine 333 (12), 757-764, 1995 | 492 | 1995 |
| Coronary-artery stenting compared with balloon angioplasty for restenosis after initial balloon angioplasty R Erbel, M Haude, HW Höpp, D Franzen, HJ Rupprecht, B Heublein, ... New England Journal of Medicine 339 (23), 1672-1678, 1998 | 474 | 1998 |
